{"count": 15, "results": [{"_id": "39957842", "pmid": 39957842, "title": "Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function.", "journal": "Liver Res", "authors": ["Ommati MM", "Mohammadi H", "Mousavi K", "Azarpira N", "Farshad O", "Dehghani R", "Najibi A", "Kamran S", "Niknahad H", "Heidari R"], "date": "2020-12-10T00:00:00Z", "doi": "10.1016/j.livres.2020.12.001", "meta_date_publication": "2021 Sep", "meta_volume": "5", "meta_issue": "3", "meta_pages": "171-180", "score": 50267.746, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestasis@@@-associated @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@nephropathy@@@ through regulating oxidative stress and mitochondrial function.", "citations": {"NLM": "Ommati MM, Mohammadi H, Mousavi K, Azarpira N, Farshad O, Dehghani R, Najibi A, Kamran S, Niknahad H, Heidari R. Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function. Liver Res. 2021 Sep;5(3):171-180. PMID: 39957842", "BibTeX": "@article{39957842, title={Metformin alleviates cholestasis-associated nephropathy through regulating oxidative stress and mitochondrial function.}, author={Ommati MM and Mohammadi H and Mousavi K and Azarpira N and Farshad O and Dehghani R and Najibi A and Kamran S and Niknahad H and Heidari R}, journal={Liver Res}, volume={5}, number={3}, pages={171-180}}"}}, {"_id": "34058177", "pmid": 34058177, "title": "Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice.", "journal": "Chem Biol Interact", "authors": ["Faradonbeh FA", "Sa II", "Lastuvkova H", "Cermanova J", "Hroch M", "Faistova H", "Mokry J", "Nova Z", "Uher M", "Nachtigal P", "Pavek P", "Micuda S"], "date": "2021-08-25T00:00:00Z", "doi": "10.1016/j.cbi.2021.109525", "meta_date_publication": "2021 Aug 25", "meta_volume": "345", "meta_issue": "", "meta_pages": "109525", "score": 50263.54, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ impairs @CHEMICAL_Bile_Acids_and_Salts @CHEMICAL_MESH:D001647 @@@bile acid@@@ homeostasis in @CHEMICAL_Ethinyl_Estradiol @CHEMICAL_MESH:D004997 @@@ethinylestradiol@@@-induced @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestasis@@@ in @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Faradonbeh FA, Sa II, Lastuvkova H, Cermanova J, Hroch M, Faistova H, Mokry J, Nova Z, Uher M, Nachtigal P, Pavek P, Micuda S. Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice. Chem Biol Interact. 2021 Aug 25;345():109525. PMID: 34058177", "BibTeX": "@article{34058177, title={Metformin impairs bile acid homeostasis in ethinylestradiol-induced cholestasis in mice.}, author={Faradonbeh FA and Sa II and Lastuvkova H and Cermanova J and Hroch M and Faistova H and Mokry J and Nova Z and Uher M and Nachtigal P and Pavek P and Micuda S}, journal={Chem Biol Interact}, volume={345}, pages={109525}}"}}, {"_id": "36147344", "pmid": 36147344, "pmcid": "PMC9486097", "title": "Literature review of the clinical characteristics of metformin-induced hepatotoxicity", "journal": "Front Pharmacol", "authors": ["Wang C", "Deng H", "Xu Y", "Liu Y"], "date": "2022-09-06T00:00:00Z", "doi": "10.3389/fphar.2022.969505", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "969505", "score": 50257.902, "text_hl": "The type of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced hepatotoxicity is not specific and can result in hepatocellular, @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestasis@@@, or mixed @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@hepatocellular liver injury@@@. ", "citations": {"NLM": "Wang C, Deng H, Xu Y, Liu Y. Literature review of the clinical characteristics of metformin-induced hepatotoxicity Front Pharmacol. 2022;13():969505. PMID: 36147344", "BibTeX": "@article{36147344, title={Literature review of the clinical characteristics of metformin-induced hepatotoxicity}, author={Wang C and Deng H and Xu Y and Liu Y}, journal={Front Pharmacol}, volume={13}, pages={969505}}"}}, {"_id": "31907698", "pmid": 31907698, "title": "Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.", "journal": "Pharm Res", "authors": ["Garzel B", "Hu T", "Li L", "Lu Y", "Heyward S", "Polli J", "Zhang L", "Huang SM", "Raufman JP", "Wang H"], "date": "2020-01-06T00:00:00Z", "doi": "10.1007/s11095-019-2753-x", "meta_date_publication": "2020 Jan 6", "meta_volume": "37", "meta_issue": "2", "meta_pages": "26", "score": 50256.645, "text_hl": "CONCLUSIONS: Repression of @GENE_ABCB11 @GENE_8647 @@@BSEP@@@ alone is sufficient to disrupt hepatic @CHEMICAL_Bile_Acids_and_Salts @CHEMICAL_MESH:D001647 @@@bile acid@@@ efflux. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Tamoxifen @CHEMICAL_MESH:D013629 @@@tamoxifen@@@ appear to be prototypes of a class of @GENE_ABCB11 @GENE_8647 @@@BSEP@@@ repressors that may cause drug-induced @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestasis@@@ through gene repression instead of direct @GENE_ABCB11 @GENE_8647 @@@BSEP@@@ inhibition.", "citations": {"NLM": "Garzel B, Hu T, Li L, Lu Y, Heyward S, Polli J, Zhang L, Huang SM, Raufman JP, Wang H. Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression. Pharm Res. 2020 Jan 6;37(2):26. PMID: 31907698", "BibTeX": "@article{31907698, title={Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression.}, author={Garzel B and Hu T and Li L and Lu Y and Heyward S and Polli J and Zhang L and Huang SM and Raufman JP and Wang H}, journal={Pharm Res}, volume={37}, number={2}, pages={26}}"}}, {"_id": "31791444", "pmid": 31791444, "pmcid": "PMC7330811", "title": "Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress", "journal": "BMB Rep", "authors": ["Lee CH", "Han JH", "Kim S", "Lee H", "Kim S", "Nam DH", "Cho DH", "Woo CH"], "date": "2020-06-01T00:00:00Z", "doi": "10.5483/BMBRep.2020.53.6.169", "meta_date_publication": "2020 Jun", "meta_volume": "53", "meta_issue": "6", "meta_pages": "311-316", "score": 50253.742, "text_hl": "These results suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can inhibit UPR induced by @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestasis@@@ in vivo.", "citations": {"NLM": "Lee CH, Han JH, Kim S, Lee H, Kim S, Nam DH, Cho DH, Woo CH. Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress BMB Rep. 2020 Jun;53(6):311-316. PMID: 31791444", "BibTeX": "@article{31791444, title={Metformin ameliorates bile duct ligation-induced acute hepatic injury via regulation of ER stress}, author={Lee CH and Han JH and Kim S and Lee H and Kim S and Nam DH and Cho DH and Woo CH}, journal={BMB Rep}, volume={53}, number={6}, pages={311-316}}"}}, {"_id": "37452836", "pmid": 37452836, "title": "Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats.", "journal": "Naunyn Schmiedebergs Arch Pharmacol", "authors": ["Barmoudeh Z", "Fouani MH", "Moslemi Z", "Azizi M", "Doustimotlagh AH", "Bardania H"], "date": "2023-07-15T00:00:00Z", "doi": "10.1007/s00210-023-02613-3", "meta_date_publication": "2023 Jul 15", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.453, "text_hl": "Histopathological analysis, biochemical analysis, and oxidative stress markers were assayed to determine the therapeutic effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ and @CHEMICAL_Melatonin @CHEMICAL_MESH:D008550 @@@Mel@@@ co-loaded liposomes on @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestasis@@@. ", "citations": {"NLM": "Barmoudeh Z, Fouani MH, Moslemi Z, Azizi M, Doustimotlagh AH, Bardania H. Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats. Naunyn Schmiedebergs Arch Pharmacol. 2023 Jul 15;():. PMID: 37452836", "BibTeX": "@article{37452836, title={Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats.}, author={Barmoudeh Z and Fouani MH and Moslemi Z and Azizi M and Doustimotlagh AH and Bardania H}, journal={Naunyn Schmiedebergs Arch Pharmacol}}"}}, {"_id": "34383728", "pmid": 34383728, "pmcid": "PMC8369431", "title": "Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury", "journal": "Am J Case Rep", "authors": ["Alanazi NS", "Alenazi TS", "Alenzi KA"], "date": "2021-08-12T00:00:00Z", "doi": "10.12659/AJCR.931418", "meta_date_publication": "2021 Aug 12", "meta_volume": "22", "meta_issue": "", "meta_pages": "e931418", "score": 50245.76, "text_hl": "The Naranjo scale indicates a probable relationship between @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@cholestatic liver injury@@@ and @CHEMICAL_Fluvastatin @CHEMICAL_MESH:D000077340 @@@fluvastatin@@@, as well as a possible relationship between @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestatic injury@@@ and @CHEMICAL_Gliclazide @CHEMICAL_MESH:D005907 @@@gliclazide@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Alanazi NS, Alenazi TS, Alenzi KA. Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury Am J Case Rep. 2021 Aug 12;22():e931418. PMID: 34383728", "BibTeX": "@article{34383728, title={Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury}, author={Alanazi NS and Alenazi TS and Alenzi KA}, journal={Am J Case Rep}, volume={22}, pages={e931418}}"}}, {"_id": "14561576", "pmid": 14561576, "title": "Metformin-induced cholestatic hepatitis.", "journal": "Endocr Pract", "authors": ["Nammour FE", "Fayad NF", "Peikin SR"], "date": "2003-07-01T00:00:00Z", "doi": "10.4158/EP.9.4.307", "meta_date_publication": "2003 Jul-Aug", "meta_volume": "9", "meta_issue": "4", "meta_pages": "307-9", "score": 50088.38, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-induced @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestatic hepatitis@@@.", "citations": {"NLM": "Nammour FE, Fayad NF, Peikin SR. Metformin-induced cholestatic hepatitis. Endocr Pract. 2003 Jul-Aug;9(4):307-9. PMID: 14561576", "BibTeX": "@article{14561576, title={Metformin-induced cholestatic hepatitis.}, author={Nammour FE and Fayad NF and Peikin SR}, journal={Endocr Pract}, volume={9}, number={4}, pages={307-9}}"}}, {"_id": "15811270", "pmid": 15811270, "title": "[Metformin-induced cholestatic hepatitis].", "journal": "Gastroenterol Hepatol", "authors": ["Barquero Romero J", "Pérez Miranda M"], "date": "2005-04-01T00:00:00Z", "doi": "10.1157/13073097", "meta_date_publication": "2005 Apr", "meta_volume": "28", "meta_issue": "4", "meta_pages": "257-8", "score": 50087.93, "text_hl": "[@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@-induced @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestatic hepatitis@@@].", "citations": {"NLM": "Barquero Romero J, Pérez Miranda M. [Metformin-induced cholestatic hepatitis]. Gastroenterol Hepatol. 2005 Apr;28(4):257-8. PMID: 15811270", "BibTeX": "@article{15811270, title={[Metformin-induced cholestatic hepatitis].}, author={Barquero Romero J and Pérez Miranda M}, journal={Gastroenterol Hepatol}, volume={28}, number={4}, pages={257-8}}"}}, {"_id": "19002567", "pmid": 19002567, "title": "Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis.", "journal": "Pharm Res", "authors": ["Jin HE", "Hong SS", "Choi MK", "Maeng HJ", "Kim DD", "Chung SJ", "Shim CK"], "date": "2009-03-01T00:00:00Z", "doi": "10.1007/s11095-008-9770-5", "meta_date_publication": "2009 Mar", "meta_volume": "26", "meta_issue": "3", "meta_pages": "549-59", "score": 50061.555, "text_hl": "In addition, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ did not demonstrate a @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@-lowering effect during IVGTT in EE @<m>DISEASE_Cholestasis</m> @DISEASE_MESH:D002779 @@@cholestasis@@@. ", "citations": {"NLM": "Jin HE, Hong SS, Choi MK, Maeng HJ, Kim DD, Chung SJ, Shim CK. Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis. Pharm Res. 2009 Mar;26(3):549-59. PMID: 19002567", "BibTeX": "@article{19002567, title={Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis.}, author={Jin HE and Hong SS and Choi MK and Maeng HJ and Kim DD and Chung SJ and Shim CK}, journal={Pharm Res}, volume={26}, number={3}, pages={549-59}}"}}]}